UTI - Dual Advantage Fixed Term Fund Series II-III (1998 Days)

· · Mutual fund · Scheme code 135510

NAV₹10.0000as on 8 Apr 2021

Fund houseUTI Mutual Fund

CategoryMutual fund

Plan & optionRegular ·

History5.5 years

Returns (%)

	1M	3M	6M	1Y	3Y	5Y	7Y	10Y	Launch
This scheme	-33.88	-32.26	-29.22	-22.75	-8.24	-0.42	—	—	-0.02

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

	Volatility	Sharpe	Sortino	Beta	Alpha	Max fall	R²
This scheme	15.0%	-0.98	-1.01	—	—	-34.0%	—

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the — months this scheme and its benchmark share.

Growth of ₹100 since launch

Drawdown from peak (%)

Every one-year period it has lived through

Windows	Worst	Median	Best	Periods that lost money
220	-4.0%	6.6%	17.9%	9%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

UTI - Dual Advantage Fixed Term Fund Series II-III (1998 Days)

·

Concentration

Number of stocks	0
Top 5 stocks	—
Top 10 stocks	—
Top 20 stocks	—
Lines in the filing	0

Largest holding	—
Largest sector	— —
Effective stocks	—
Sectors held	0
Cash	0.00%

Effective stocks is what the concentration works out to: a fund holding 0 names but most of its money in a few behaves like a fund of —. Cash includes repo and TREPS, which every fund parks money in overnight.

UTI - Dual Advantage Fixed Term Fund Series II-III (1998 Days)

· · holdings

UTI - Dual Advantage Fixed Term Fund Series II-III (1998 Days)

· · where the money sits

A ₹10,000 monthly SIP over five years

Invested	Value	Gain	XIRR
₹600,000	₹473,408	₹-126,592	-9.27%

XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has been invested for a different length of time.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 28 Sep 2026.